NASDAQ:LMAT - LeMaitre Vascular Stock Price, Forecast & News

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

LeMaitre Vascular announced a quarterly dividend on Monday, February 10th. Investors of record on Tuesday, March 3rd will be paid a dividend of $0.095 per share on Thursday, March 19th. This represents a $0.38 annualized dividend and a dividend yield of 1.25%. The ex-dividend date of this dividend is Monday, March 2nd. This is a positive change from LeMaitre Vascular's previous quarterly dividend of $0.09. View LeMaitre Vascular's Dividend History.

LeMaitre Vascular Inc (NASDAQ:LMAT) announced its quarterly earnings results on Thursday, February, 6th. The medical instruments supplier reported $0.23 EPS for the quarter, meeting the consensus estimate of $0.23. The medical instruments supplier had revenue of $30.20 million for the quarter, compared to analysts' expectations of $30.44 million. LeMaitre Vascular had a net margin of 15.30% and a return on equity of 12.85%. LeMaitre Vascular's revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the company posted $0.30 EPS. View LeMaitre Vascular's Earnings History.

LeMaitre Vascular is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for LeMaitre Vascular.

LeMaitre Vascular updated its FY20 earnings guidance on Thursday, February, 6th. The company provided EPS guidance of $0.90-$0.98 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.95. The company issued revenue guidance of $127.4-$130.8 million, compared to the consensus revenue estimate of $129.41 million.

3 analysts have issued 12 month price objectives for LeMaitre Vascular's stock. Their forecasts range from $38.00 to $40.00. On average, they anticipate LeMaitre Vascular's share price to reach $39.33 in the next twelve months. This suggests a possible upside of 29.5% from the stock's current price. View Analyst Price Targets for LeMaitre Vascular.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LeMaitre Vascular.

Media stories about LMAT stock have been trending somewhat positive on Saturday, according to InfoTrie. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. LeMaitre Vascular earned a media sentiment score of 0.5 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for LeMaitre Vascular.

Some companies that are related to LeMaitre Vascular include Glaukos (GKOS), Irhythm Technologies (IRTC), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), AtriCure (ATRC), Silk Road Medical (SILK), Cardiovascular Systems (CSII), Atrion (ATRI), Shockwave Medical (SWAV), Tactile Systems Technology (TCMD), Luminex (LMNX), Axonics Modulation Technologies (AXNX), Cryolife (CRY), Intersect ENT (XENT) and Orthofix Medical (OFIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include Canopy Growth (CGC), AbbVie (ABBV), Sociedad Quimica y Minera de Chile (SQM), Gilead Sciences (GILD), NVIDIA (NVDA), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), Adobe (ADBE), Boeing (BA) and Teva Pharmaceutical Industries (TEVA).

LeMaitre Vascular's stock is owned by a number of of retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (8.58%), Janus Henderson Group PLC (3.31%), State Street Corp (3.28%), Copeland Capital Management LLC (2.76%), Principal Financial Group Inc. (2.67%) and Russell Investments Group Ltd. (2.24%). Company insiders that own LeMaitre Vascular stock include David B Roberts, George W Lemaitre, Joseph P Pellegrino Jr, Lawrence J Jasinski, Michael H Thomas and Trent G Kamke. View Institutional Ownership Trends for LeMaitre Vascular.

LMAT stock was sold by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan, THB Asset Management, Algert Global LLC, Bank of New York Mellon Corp, Oxford Asset Management LLP, Arizona State Retirement System, Conestoga Capital Advisors LLC and GW&K Investment Management LLC. Company insiders that have sold LeMaitre Vascular company stock in the last year include David B Roberts, George W Lemaitre, Joseph P Pellegrino Jr, Lawrence J Jasinski, Michael H Thomas and Trent G Kamke. View Insider Buying and Selling for LeMaitre Vascular.

LMAT stock was purchased by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Foundry Partners LLC, Russell Investments Group Ltd., Goldman Sachs Group Inc., Cadence Capital Management LLC, Aviva PLC, Wedge Capital Management L L P NC and State Street Corp. View Insider Buying and Selling for LeMaitre Vascular.

Shares of LMAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LMAT stock can currently be purchased for approximately $30.38.

LeMaitre Vascular has a market capitalization of $607.33 million and generates $117.23 million in revenue each year. The medical instruments supplier earns $17.93 million in net income (profit) each year or $0.88 on an earnings per share basis. View Additional Information About LeMaitre Vascular.

The official website for LeMaitre Vascular is http://www.lemaitre.com/.

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at 781-221-2266.